among
rna
virus
order
nidoviral
stand
includ
virus
largest
rna
genom
current
known
nidovirus
employ
complex
rnasynthes
machineri
compris
varieti
nonstructur
protein
nsp
one
postul
driver
expans
nidoviru
genom
presenc
proofread
exoribonucleas
exon
belong
deddh
famili
exon
may
enhanc
fidel
rna
synthesi
correct
nucleotid
incorpor
error
made
rnadepend
rna
polymeras
review
current
understand
exon
evolut
structur
function
experiment
data
deriv
studi
exon
domain
coronavirus
cov
trigger
bioinformaticsbas
identif
exon
genom
sever
acut
respiratori
syndrom
coronaviru
sarscov
rel
although
convinc
data
support
proofread
hypothesi
obtain
biochem
assay
studi
cov
mutant
lack
exon
function
featur
exon
nidoviru
famili
remain
character
remark
viabl
exon
knockout
mutant
obtain
two
cov
mous
hepat
viru
mhv
sarscov
whose
rna
synthesi
replic
kinet
mildli
affect
lack
exon
function
sever
cov
speci
exon
inactiv
toler
knockout
mutant
could
rescu
launch
use
revers
genet
system
suggest
exon
also
critic
primari
viral
rna
synthesi
properti
poorli
match
profil
enzym
would
mere
boost
longterm
replic
fidel
cov
exon
resid
bifunct
replicas
subunit
whose
ctermin
part
methyltransferas
activ
crystal
structur
sarscov
shed
light
interplay
two
domain
interact
cofactor
strongli
enhanc
exon
activ
vitro
assay
elucid
structurefunct
relationship
exon
interact
viral
andor
host
member
cov
replic
machineri
key
understand
enzym
role
viral
rna
synthesi
pathogenesi
may
contribut
design
new
approach
combat
emerg
nidovirus
rna
virus
typic
exhibit
high
mutat
frequenc
intrins
biolog
properti
facilit
rapid
adapt
viru
chang
circumst
major
contributor
frequent
outbreak
mutat
newli
emerg
rna
virus
human
livestock
host
organ
poor
fidel
rna
viru
genom
replic
attribut
primarili
fact
error
made
viral
rnadepend
rna
polymeras
rdrp
go
uncorrect
lack
proofread
result
quasispeci
popul
close
relat
viral
genom
subject
continu
natur
select
accumul
excess
number
deleteri
mutat
result
error
catastroph
low
fidel
replic
thought
restrict
genom
size
rna
viru
famili
well
kilobas
steinhauer
et
al
drake
holland
eigen
evolutionari
tradeoff
rna
viru
genom
size
replic
fidel
adapt
capac
explor
fundament
perspect
context
antivir
drug
develop
crotti
et
al
balanc
quasispeci
divers
viral
fit
appear
easili
disturb
suggest
rna
virus
gener
may
oper
close
error
threshold
pfeiffer
kirkegaard
vignuzzi
et
al
manrubia
et
al
clearli
absenc
countermeasur
reduc
overal
error
rate
similar
issu
would
expect
upon
signific
expans
rna
viru
genom
size
largest
rna
genom
current
known
found
order
nidoviral
order
positivestrand
rna
rna
virus
includ
coronaviru
cov
famili
beststudi
taxon
recent
nidoviru
addit
bukhari
et
al
saberi
et
al
increas
known
upper
limit
rna
genom
size
kb
cov
kb
nidoviru
identifi
planarian
host
name
planarian
secretori
cell
nidoviru
pscnv
saberi
et
al
year
ago
indepth
bioinformat
analysi
genom
proteom
sever
acut
respiratori
syndrom
coronaviru
sarscov
alexand
gorbalenya
cowork
identifi
exoribonucleas
exon
signatur
sequenc
domain
embed
replicas
polyprotein
cov
nidovirus
similarli
larg
rna
genom
specul
role
proofread
enzym
evolut
larg
nidoviru
genom
snijder
et
al
shortli
groundbreak
discoveri
exon
activ
demonstr
biochem
sarscov
minskaia
et
al
andfollow
inactiv
revers
genet
inde
implic
enhanc
cov
replic
fidel
eckerl
et
al
subsequ
enzym
subject
virolog
biochem
structur
genet
studi
evid
strongli
support
proofread
exoribonucleas
hypothesi
accumul
particular
sarscov
murin
hepat
cov
mhv
bouvet
et
al
smith
denison
summar
time
quit
differ
observ
made
multipl
cov
highlight
need
extens
experiment
character
import
function
uniqu
exon
domain
within
cov
famili
nidoviru
subgroup
exon
acquisit
nidovir
ancestor
subsequ
develop
benefici
interplay
viral
rna
rdrp
subissi
et
al
ferron
et
al
thought
key
step
reliev
constraint
genom
size
expans
viru
lineag
nga
et
al
strikingli
replic
arterivirus
nidoviru
famili
smallest
genom
kb
depend
presenc
exon
domain
viral
replicas
snijder
et
al
suggest
either
diverg
nidovirus
exon
acquisit
lost
exon
later
stage
evolutionari
trajectori
order
nidoviral
current
compris
formal
recogn
viru
speci
rna
virus
classifi
nine
viru
famili
across
seven
differ
subord
siddel
et
al
agent
infect
strike
varieti
vertebr
invertebr
host
includ
mammal
bird
amphibian
fish
reptil
arthropod
mollusc
helminth
addit
nidoviru
genom
sequenc
continu
describ
due
extens
metagenomicsbas
viru
discoveri
effort
past
decad
saberi
et
al
adequ
classif
undoubtedli
requir
creation
addit
nidoviru
taxa
unfortun
biolog
possibl
pathogen
featur
novel
nidovirus
remain
uncharacter
thu
far
shi
et
al
shi
et
al
groundwork
nidoviru
order
laid
late
first
fulllength
genom
sequenc
corona
arteri
torovirus
reveal
strike
similar
level
genom
organ
express
moreov
conserv
array
replicas
domain
distantli
relat
genom
point
toward
common
ancestri
core
replic
machineri
includ
rnadepend
rna
polymeras
rdrp
helicas
enzym
den
boon
et
al
find
surpris
time
particular
given
differ
appear
featur
corona
arteri
toroviru
particl
larg
differ
genom
size
rang
less
kb
arteriviru
equin
arter
viru
eav
kb
cov
like
mhv
latter
properti
place
cov
far
apart
viral
famili
character
final
decad
centuri
uniqu
posit
also
rais
question
process
fidel
cov
rnasynthes
machineri
particularli
light
develop
emerg
rna
viru
quasispeci
concept
notion
rna
viru
genom
size
constrain
high
mutat
rate
rdrp
see
advent
metagenom
taken
understand
nidoviru
host
genom
divers
next
level
shi
et
al
shi
et
al
zumla
et
al
even
though
new
sequenc
remain
analyz
detail
mani
branch
revis
nidoviru
order
remain
spars
popul
term
rna
genom
size
known
upper
limit
increas
kb
see
time
former
gap
exondefici
arteriviru
group
largegenom
nidovirus
contain
exon
signatur
sequenc
larg
disappear
clearli
genom
size
unlik
sole
factor
determin
requir
exon
type
proofread
function
factor
particular
rdrp
properti
may
also
promin
influenc
replic
fidel
rapid
expans
nidoviru
order
highlight
strict
conserv
array
five
core
replicas
domain
main
proteas
ii
nidoviru
rdrpassoci
nucleotidyl
transferas
niran
iii
rdrp
iv
znbind
domain
zbd
v
superfamili
helicas
domain
zbd
alway
associ
figur
lehmann
et
al
saberi
et
al
present
exon
domain
found
immedi
downstream
nidoviruswid
conserv
domain
often
resid
bifunct
replicas
cleavag
product
also
contain
methyltransferas
activ
chen
et
al
bouvet
et
al
case
cov
nonstructur
protein
nsp
size
exon
domain
appear
rather
variabl
differ
nidoviru
lineag
roughli
amino
acid
aa
residu
depend
presenc
absenc
two
intern
zinc
finger
domain
nga
et
al
unpublish
observ
figur
mention
novel
metagenomicsderiv
nidovirus
know
genom
sequenc
replic
properti
enzym
remain
biolog
uncharacter
thu
far
clearli
differ
cov
track
record
import
group
zoonot
human
veterinari
pathogen
except
durzynska
et
al
also
structurefunct
analysi
nidovir
exon
enzym
base
covderiv
variant
enzym
focu
attent
point
forward
like
nidovirus
cov
encod
two
larg
replicas
polyprotein
figur
latter
deriv
ribosom
frameshift
occur
upstream
termin
codon
primari
translat
product
roughli
residu
process
two
three
intern
proteas
resid
ziebuhr
et
al
gorbalenya
et
al
result
nsp
cleavag
product
assembl
ribonucleoprotein
complex
produc
differ
type
viral
rna
transcript
cytoplasm
host
cell
cov
infect
induc
format
unusu
doublemembran
structur
thought
support
viral
rna
synthesi
gosert
et
al
knoop
et
al
synthesi
nest
set
subgenom
sg
mrna
one
origin
nidoviru
hallmark
l
nidu
nest
promin
cov
featur
drive
express
gene
locat
downstream
encod
structur
accessori
protein
figur
addit
complex
cov
rna
synthesi
fact
sg
mrna
produc
set
subgenomelength
templat
cotermin
fulllength
negativestrand
templat
use
genom
replic
mechanist
detail
cov
rna
synthesi
regul
summar
elsewher
pasternak
et
al
sawicki
et
al
sola
et
al
past
year
cov
replicas
protein
character
use
combin
bioinformat
biochemistri
structur
biolog
revers
genet
vitro
biochem
assay
describ
predict
replic
enzym
function
increasingli
support
avail
structur
inform
sever
key
cov
enzym
probe
sitedirect
mutagenesi
either
use
vitro
assay
launch
engin
mutant
cov
genom
clone
cdna
templat
cov
replicas
subunit
intim
associ
viral
rna
synthesi
either
enzymat
entiti
import
cofactor
review
see
decroli
et
al
denison
et
al
neuman
et
al
sevajol
et
al
snijder
et
al
key
player
subunit
contain
rdrp
hel
domain
respect
protein
also
carri
uniqu
ntermin
domain
niran
zbd
respect
nidovirusspecif
marker
whose
function
import
remain
studi
detail
lehmann
et
al
posthuma
et
al
saberi
et
al
kirchdoerf
ward
sever
nsp
assign
function
cov
mrna
cap
cap
modif
decroli
et
al
decroli
et
al
chen
et
al
bouvet
et
al
snijder
et
al
process
critic
viral
translat
innat
immun
evas
zust
et
al
sever
smaller
subunit
discuss
appear
act
crucial
cofactor
nsp
nspnsp
interact
also
assum
highli
relev
proofread
activ
domain
bouvet
et
al
subissi
et
al
ferron
et
al
clearli
understand
cov
replicas
activ
assembl
viral
rna
synthes
machineri
continu
develop
may
ultim
help
explain
evolutionari
success
nidovirus
larg
ctermin
twothird
cov
subunit
occupi
canon
rdrp
domain
contain
commonli
encount
motif
f
gorbalenya
et
al
sevajol
et
al
posthuma
et
al
kirchdoerf
ward
conserv
aspart
motif
motif
c
presum
respons
coordin
two
essenti
metal
ion
activ
site
te
velthui
et
al
ahn
et
al
subissi
et
al
current
knowledg
cov
rdrp
base
studi
sarscov
summar
ie
replicas
orf
four
common
cov
structur
protein
gene
e
n
orf
encod
accessori
protein
bottom
half
scheme
summar
proteolyt
process
domain
organ
replicas
polyprotein
latter
produc
ribosom
frameshift
plpro
green
red
proteas
cognat
cleavag
site
indic
match
color
result
cleavag
product
nonstructur
protein
nsp
indic
conserv
replicas
domain
relev
review
see
main
text
refer
nsp
function
domain
abbrevi
correspond
nsp
number
plpro
papainlik
proteinas
main
proteinas
tm
transmembran
domain
niran
nidoviru
rdrpassoci
nucleotidyl
transferas
rdrp
rnadepend
rna
polymeras
zbd
zincbind
domain
superfamili
helicas
exon
exoribonucleas
methyl
transferas
endou
uridylatespecif
endoribonucleas
omtas
omethyl
transferas
utr
untransl
region
b
comparison
predict
domain
organ
replicas
polyprotein
select
member
nine
famili
current
classifi
within
order
nidoviral
ictv
releas
adapt
bukhari
et
al
permiss
domain
predict
use
hhpredsearch
sode
zimmermann
et
al
abbrevi
see
legend
panel
genbank
access
number
sequenc
use
sarscoronaviru
human
coronaviru
bovin
nidoviru
sectoviru
white
bream
viru
gillassoci
viru
charybniviru
paguroniviru
alphamesoniviru
turriniviru
equin
arter
viru
aplysia
abyssoviru
planidoviru
structur
predict
domain
describ
earli
xu
et
al
crystal
structur
protein
still
lack
howev
recent
cryoemderiv
structur
sarscov
complex
two
copi
one
copi
report
kirchdoerf
ward
like
rna
viral
rdrp
cov
rdrp
display
characterist
cup
right
hand
organ
includ
thumb
palm
finger
subdomain
xu
et
al
sexton
et
al
posthuma
et
al
kirchdoerf
ward
socal
prime
loop
typic
short
consid
signatur
primerdepend
rna
synthesi
lack
technic
challeng
obtain
stabl
activ
recombin
hamper
biochem
character
cov
rdrp
activ
poor
enzymat
activ
observ
initi
primerdepend
figur
amino
acid
sequenc
align
select
nidoviru
exon
domain
includ
character
experiment
discuss
review
mainli
deriv
member
cov
famili
sarscov
merscov
tgev
mhv
ibv
porcin
delta
cov
pdcov
wbv
sarscov
secondari
structur
pdb
indic
top
color
accord
follow
domain
organ
site
cyan
exon
domain
orang
hing
region
purpl
domain
blue
fulli
conserv
residu
red
font
box
wherea
partial
conserv
residu
display
red
font
conserv
catalyt
residu
residu
involv
format
zinc
finger
mark
asterisk
circl
respect
b
weblogo
highlight
three
core
motif
exon
domain
famili
exonucleas
belong
rna
synthesi
de
novo
initi
report
review
snijder
et
al
kirchdoerf
ward
howev
presenc
small
subunit
vitro
primer
extens
activ
could
substanti
increas
de
novo
initi
observ
long
templat
correspond
termin
sequenc
sarscov
genom
subissi
et
al
recombin
sarscov
previous
shown
multimer
ringshap
hexadecam
propos
act
process
factor
copi
long
cov
rna
genom
zhai
et
al
thu
cov
activ
postul
depend
format
tripartit
complex
least
step
rna
synthesi
exact
stoichiometri
complex
remain
studi
detail
particularli
light
recent
publish
cryoem
structur
sarscov
protein
complex
singl
dimer
plu
addit
monom
rather
hexadecam
kirchdoerf
ward
note
vitro
rdrp
activ
latter
complex
remain
demonstr
furthermor
felin
coronaviru
fcov
despit
structur
similar
sarscov
equival
higherord
complex
quit
differ
hexadecam
describ
heterotrim
consist
two
copi
singl
copi
xiao
et
al
earli
vitro
assay
use
recombin
sarscov
reveal
rna
polymeras
activ
typic
gener
product
six
nucleotid
imbert
et
al
activ
implic
prime
cov
rna
synthesi
particularli
light
predict
absenc
prime
loop
domain
see
thu
propos
act
primas
could
synthes
small
oligonucleotid
extend
howev
studi
activ
tripartit
complex
de
novo
initi
detect
domain
inactiv
motif
c
substitut
subissi
et
al
recent
vitro
studi
employ
human
coronaviru
hcov
could
establish
primas
rdrp
activ
instead
reveal
termin
adenylyl
transferas
activ
may
serv
equip
viral
transcript
poli
tail
tvarogova
et
al
although
import
cofactor
rna
synthesi
undisput
interplay
clearli
remain
investig
detail
particular
sinc
issu
primer
originusag
seem
wide
open
bioinformaticsdriven
discoveri
nidovir
exon
domain
base
distant
sequenc
similar
cellular
homolog
belong
dedd
superfamili
exonucleas
proofread
exonucleas
domain
escherichia
coli
dna
polymeras
snijder
et
al
subsequ
predict
exoribonucleas
activ
confirm
use
vitro
assay
recombin
sarscov
synthet
rna
substrat
minskaia
et
al
use
revers
genet
author
also
demonstr
exon
activ
critic
viabil
alphacoronaviru
inactiv
enzym
activ
site
result
sever
defect
overal
viral
rna
synthesi
failur
recov
infecti
viral
progeni
shortli
thereaft
strikingli
differ
find
obtain
correspond
exonknockout
mutant
two
betacoronavirus
mhv
sarscov
eckerl
et
al
eckerl
et
al
somewhat
crippl
viabl
cell
cultur
strong
support
origin
hypothesi
exon
may
act
proofread
enzym
exon
inactiv
found
confer
mutat
phenotyp
evid
increas
mutat
frequencyrel
wildtyp
wt
control
replic
passag
cell
cultur
abil
exon
excis
mismatch
nucleotid
doublestrand
ds
rna
substrat
demonstr
vitro
use
sarscov
bouvet
et
al
activ
strikingli
enhanc
addit
suggest
two
subunit
oper
heterodim
mismatch
repair
mechan
serv
promot
fidel
cov
rna
synthesi
followup
studi
marseil
laboratori
also
describ
vitro
associ
sarscov
tripartit
complex
subissi
et
al
demonstr
exon
effici
excis
ribavirin
monophosph
possibl
explain
broadspectrum
antivir
drug
poorli
activ
cov
snijder
et
al
ferron
et
al
meantim
becom
clear
exoncontain
subunit
cov
replicas
kda
size
bifunct
protein
genet
screen
approach
yeast
system
reveal
ctermin
domain
exhibit
methyltransferas
activ
chen
et
al
follow
vitro
character
activ
enzym
implic
presum
termin
cap
structur
cov
mrna
modif
critic
mrna
recognit
cellular
translat
machineri
bouvet
et
al
bimodular
organ
conserv
nidoviru
famili
domain
lack
eg
torovirus
bafinivirus
durzynska
et
al
sever
recent
discov
nidovirus
figur
lauber
et
al
bukhari
et
al
saberi
et
al
latter
find
rais
new
question
mrna
cap
pathway
employ
particular
viru
group
nidovirus
larg
crystal
structur
sarscov
complex
cofactor
pdb
entri
reveal
sever
uniqu
structur
function
featur
et
al
ferron
et
al
discuss
structur
function
detail
follow
extens
descript
revers
genet
data
obtain
exonknockout
mutant
variou
cov
function
consider
cov
exon
domain
origin
identifi
basi
sequenc
similar
distant
cellular
homolog
snijder
et
al
classifi
superfamili
dedd
exonucleas
contain
proofread
domain
mani
dna
polymeras
well
eukaryot
prokaryot
exonucleas
zuo
deutscher
enzym
catalyz
excis
nucleosid
monophosph
nucleic
acid
direct
use
mechan
depend
two
dival
metal
ion
reactiv
water
molecul
deutscher
marlor
bees
steitz
steitz
steitz
name
dedd
superfamili
deriv
four
conserv
activ
site
residu
distribut
three
canon
motif
ii
iii
figur
b
primari
structur
bernad
et
al
origin
sarscov
residu
motif
motif
ii
motif
iii
identifi
put
activ
site
residu
snijder
et
al
minskaia
et
al
subsequ
sarscov
crystal
structur
reveal
exon
fact
deed
enzym
instead
identifi
acid
activ
site
residu
motif
ii
et
al
interestingli
align
exon
sequenc
differ
nidoviru
taxa
sarscov
fulli
conserv
wherea
equival
altern
e
figur
b
structur
studi
et
al
ferron
et
al
also
reveal
presenc
fifth
catalyt
residu
motif
iii
identifi
exon
member
deddhdeedh
subfamili
barn
et
al
zuo
deutscher
contrast
exon
activ
infer
bioinformat
analysi
presenc
ctermin
domain
predict
enzym
discov
upon
express
tgev
sarscov
yeast
saccharomyc
cerevisia
could
rescu
mutant
yeast
strain
lack
nativ
chen
et
al
activ
corrobor
use
biochem
assay
purifi
recombin
sarscov
found
capabl
ad
methyl
group
nonmethyl
cap
analog
gtp
substrat
presenc
sadenosyl
methionin
sam
methyl
donor
chen
et
al
jin
et
al
alanin
scan
mutagenesi
vitro
assay
highlight
two
cluster
residu
key
mtase
activ
chen
et
al
import
first
cluster
canon
sambind
motif
dxgxpxga
figur
b
consist
residu
confirm
hlabel
sam
crosslink
experi
chen
et
al
second
cluster
encompass
residu
crystal
structur
form
constrict
pocket
hold
gtp
moieti
cap
structur
gpppa
two
helix
figur
manner
posit
posit
cap
close
proxim
methyl
donor
thu
facilit
transfer
inlin
mechan
et
al
compar
sequenc
analysi
domain
reveal
number
residu
crucial
substrat
ligand
bind
conserv
among
homolog
enzym
differ
nidovirus
et
al
ferron
et
al
saberi
et
al
biochem
analysi
confirm
two
enzymat
activ
function
distinct
chen
et
al
physic
independ
also
deduc
structur
studi
summar
et
al
ferron
et
al
howev
delet
within
exon
domain
ntermin
truncat
amino
acid
alanin
substitut
ntermin
domain
drastic
attenu
complet
abolish
vitro
activ
chen
et
al
although
chang
may
affect
overal
protein
structur
function
result
may
also
indic
two
enzymat
domain
structur
interconnect
activ
depend
integr
ntermin
exon
domain
hand
exon
domain
directli
involv
sam
bind
chen
et
al
activ
depend
interact
strongli
enhanc
exon
activ
bouvet
et
al
crystal
structur
sarscov
confirm
bimodular
protein
compos
exon
domain
accompani
ntermin
structur
domain
figur
overal
protein
architectur
follow
flexibl
ntermin
domain
form
dock
site
ii
exon
domain
iii
flexibl
hing
region
consist
loop
three
strand
iv
ctermin
domain
et
al
ferron
et
al
cov
exon
domain
fold
reminisc
member
dedd
exonucleas
superfamili
derbyshir
et
al
core
form
twist
central
compos
five
flank
five
et
al
ferron
et
al
central
domain
insert
structur
contain
protrud
form
second
antiparallel
bind
figur
interact
figur
similar
hand
fist
conform
ferron
et
al
finger
hand
form
flexibl
ntermin
region
residu
residu
antiparallel
protrud
exon
domain
residu
palm
compos
residu
top
residu
side
figur
interact
induc
conform
chang
ntermin
region
exon
modul
distanc
catalyt
residu
back
palm
consequ
impact
exon
activ
ferron
et
al
cov
exon
structur
share
conserv
gener
architectur
deddtyp
exonucleas
includ
proofread
exon
domain
like
klenow
fragment
e
coli
dna
polymeras
subunit
dna
polymeras
iii
et
al
anoth
viral
exonucleas
yekwa
et
al
current
peerreview
hand
distinguish
featur
ntermin
interact
domain
structur
contain
also
interact
two
zinc
finger
zf
motif
first
zinc
finger
place
form
residu
second
zinc
finger
compris
residu
locat
see
figur
activ
site
residu
embed
within
see
figur
conserv
among
nidovirus
except
pscnv
saberi
et
al
sitedirect
mutagenesi
studi
suggest
contribut
structur
stabil
sinc
solubl
sarscov
could
obtain
upon
disrupt
import
catalysi
replac
import
residu
abolish
enzymat
activ
recombin
exon
et
al
exon
domain
separ
hing
region
conserv
across
cov
hing
may
allow
signific
movement
two
enzymat
domain
allow
later
rotat
movement
ctermin
domain
respect
ntermin
domain
mayb
import
coordin
activ
figur
domain
exhibit
canon
rossmann
fold
commonli
found
among
rna
viru
mtase
rna
cap
mtase
byszewska
et
al
chouhan
et
al
belong
five
class
samdepend
mtase
schubert
et
al
ad
anoth
dimens
uniqu
structur
featur
bifunct
protein
figur
ferron
et
al
gener
rossmann
fold
follow
characterist
architectur
seven
parallel
hydrogenbond
compos
core
structur
least
three
side
rao
rossmann
ferron
et
al
compris
total
five
central
compos
five
instead
seven
addit
domain
end
modif
stabil
local
hydrophob
environ
found
samdepend
mtase
martin
mcmillan
zf
motif
consist
locat
strand
helix
import
proper
fold
region
figur
three
zf
motif
specif
structur
signatur
first
biochem
assay
purifi
sarscov
demonstr
capabl
hydrolyz
doublestrand
ds
singlestrand
ss
rna
substrat
direct
prefer
dsrna
substrat
minskaia
et
al
exon
activ
found
rna
sequencespecif
dna
substrat
degrad
ribonucleas
activ
depend
presenc
dival
metal
ion
strongli
reduc
lost
upon
substitut
predict
catalyt
residu
motif
ii
iii
alanin
minskaia
et
al
wherea
basal
exon
activ
requir
presenc
cofactor
minskaia
et
al
chen
et
al
bouvet
et
al
demonstr
sarscov
exon
activ
enhanc
presenc
small
subunit
cov
replicas
also
serv
cofactor
omethyltransferas
omtas
activ
bouvet
et
al
mutagenesi
surfac
residu
alanin
mani
case
disrupt
interact
lead
signific
reduct
exon
activ
conclus
share
common
interact
surfac
bouvet
et
al
bouvet
et
al
complex
preferenti
degrad
dsrna
substrat
suggest
heterodimer
chang
exon
substrat
specif
bouvet
et
al
furthermor
rna
substrat
end
duplex
structur
like
stabl
hairpin
fulli
basepair
rna
substrat
also
effici
hydrolyz
complex
bouvet
et
al
importantli
assay
intend
mimic
rdrp
incorpor
error
sarscov
complex
abl
excis
termin
mismatch
nucleotid
dsrna
substrat
bouvet
et
al
elabor
analysi
exon
substrat
use
specif
suggest
catalysi
determin
presenc
mismatch
rather
natur
misincorpor
nucleotid
bouvet
et
al
ferron
et
al
howev
stretch
termin
mismatch
nucleotid
increas
beyond
nucleotid
sharp
decreas
excis
activ
observ
bouvet
et
al
compar
vitro
mismatch
excis
activ
report
recent
exon
domain
bafiniviru
white
bream
viru
wbv
use
dsrna
substrat
contain
three
mismatch
durzynska
et
al
assay
perform
use
wbv
equival
alon
homolog
seem
encod
bafinivirus
thu
far
studi
constitut
descript
vitro
exon
activ
nidoviru
belong
cov
famili
studi
provid
first
biochem
evid
exon
like
concert
tripartit
rdrp
complex
cov
may
function
proofread
enzym
preferenti
target
termin
singl
mismatch
inde
sarscov
complex
abl
associ
retain
rna
synthesi
exoribonucleas
activ
subissi
et
al
although
structur
basi
interact
domain
remain
elucid
vitro
studi
reveal
exon
domain
involv
ferron
et
al
recent
biochem
studi
provid
insight
interplay
sarscov
rdrp
complex
heterodim
ferron
et
al
use
primertempl
substrat
contain
mismatch
end
primer
extens
primer
bare
observ
suggest
sarscov
rdrp
encount
kinet
block
extend
substrat
termin
mismatch
ferron
et
al
strikingli
addit
assay
appear
reliev
constraint
fulllength
polymer
product
observ
suggest
exon
remov
mismatch
polymer
resum
sequenc
rna
product
reveal
correct
sequenc
ferron
et
al
similarli
ribavirin
monophosph
guanosin
analog
effici
excis
rna
substrat
presenc
ferron
et
al
togeth
mutat
phenotyp
observ
exonknockout
mutant
sarscov
mhv
see
data
strongli
suggest
exon
contribut
fidel
cov
rna
synthesi
strike
vitro
singlenucleotid
incorpor
assay
sarscov
rdrp
complex
without
display
lower
fidel
rdrp
dengu
viru
flaviviru
threefold
smaller
genom
ferron
et
al
clearli
direct
vitro
comparison
properti
distantli
relat
viral
rdrp
straightforward
moreov
percept
fragment
best
come
biochem
evolut
rdrp
exon
featur
follow
postul
acquisit
latter
ancestr
nidoviru
snijder
et
al
nga
et
al
exon
acquisit
may
inde
facilit
genom
expans
unknown
extent
may
also
relax
nucleotid
select
rdrp
therefor
fidel
rna
synthesi
would
line
biochem
observ
outlin
ferron
et
al
would
also
leav
space
possibl
nidovirus
may
exist
combin
use
exon
intrins
rdrp
fidel
substanti
higher
observ
presentday
cov
fact
also
scenario
may
contribut
expand
nidovir
genom
current
known
upper
limit
kb
pscnv
saberi
et
al
potenti
beyond
light
would
highli
interest
perform
similar
vitro
assay
establish
compar
intrins
rdrp
fidel
divers
nidovirus
includ
longest
genom
natur
lack
exon
domain
ferron
et
al
subsequ
nucleotid
incorpor
assay
combin
rdrp
cognat
exon
may
provid
import
insight
biochem
synergi
two
enzym
may
ultim
allow
us
correl
intrins
rdrp
fidel
exon
activ
across
broad
spectrum
virus
includ
nidoviru
order
studi
ziebuhr
laboratori
demonstr
sarscov
vitro
exoribonucleas
activ
minskaia
et
al
also
describ
first
engin
exonknockout
cov
mutant
howev
biosafeti
reason
experi
perform
use
alphacoronaviru
rather
betacoronaviru
sarscov
intracellular
accumul
rna
found
sever
reduc
approxim
log
sever
exon
activ
site
mutant
motif
ii
iii
moreov
rel
molar
ratio
sg
mrna
alter
product
altern
sg
transcript
suspect
base
analysi
low
amount
viral
rna
produc
transfect
cell
importantli
infecti
viru
progeni
could
recov
medium
cell
transfect
fulllength
rna
carri
exoninactiv
mutat
consequ
exon
activ
conclud
critic
replic
minskaia
et
al
sarscov
rather
subject
initi
revers
genet
studi
conclus
would
quit
differ
subsequ
work
denison
baric
laboratori
show
replic
equival
exonknockout
mutant
sarscov
mhv
affect
certainli
abolish
eckerl
et
al
eckerl
et
al
case
substitut
conserv
acid
residu
either
motif
sarscov
mutant
motif
iii
mutant
alanin
mhv
mutat
reduc
overal
viral
rna
synthesi
genom
sg
rna
delay
replic
sever
hour
wherea
also
specif
chang
sg
mrna
synthesi
observ
reduc
product
mhv
progeni
titer
exonknockout
mutant
reduc
log
plaqu
size
exonknockout
mutant
also
show
extrem
heterogen
eckerl
et
al
correspond
sarscov
mutant
progeni
titer
fourfold
reduc
without
clear
overal
chang
replic
kinet
eckerl
et
al
although
intracellular
rna
synthesi
studi
detail
upon
serial
passag
cultur
cell
sequenc
analysi
use
convent
nextgener
techniqu
reveal
genom
exonknockout
mhv
sarscov
mutant
accumul
mutat
parent
control
thu
provid
direct
experiment
evid
connect
exon
activ
cov
replic
fidel
eckerl
et
al
eckerl
et
al
investig
mutat
phenotyp
vivo
mutant
engin
mouseadapt
sarscov
backbon
graham
et
al
vitro
character
mutant
progeni
titer
reduc
less
log
quantit
rtpcr
data
indic
accumul
wildtyp
mutant
genom
initi
roughli
equival
h
pi
mutant
genom
accumul
lower
level
later
infect
h
pi
possibl
due
rapid
accumul
unfavor
mutat
graham
et
al
similar
result
obtain
upon
passag
cell
cultur
sarscov
mutant
exhibit
increas
mutat
frequenc
virul
mutant
attenu
result
strongli
reduc
diseas
expedit
viru
clearanc
graham
et
al
longterm
persist
infect
scid
mice
allow
comparison
mutat
load
day
reveal
mutat
across
genom
progeni
exondefici
sarscov
expect
due
reduc
replic
fidel
andor
impair
overal
replic
capac
mhv
sarscov
exon
mutant
display
increas
sensit
mutagen
agent
like
nucleosid
analog
smith
et
al
similarli
mhv
mutant
interact
cofactor
predict
disturb
two
mutat
sensit
wt
viru
smith
et
al
although
find
could
taken
support
hypothesi
complex
act
proofread
enzym
situat
like
complex
specif
singl
alanin
substitut
one
posit
target
mhv
prove
lethal
sarscov
mutant
bouvet
et
al
also
mutat
disturb
interact
lethal
thu
much
stronger
impact
sarscov
viabil
direct
inactiv
exon
enzymat
activ
bouvet
et
al
take
account
interact
region
overlap
ferron
et
al
hypothes
mutat
interfer
activ
complex
clearli
rais
import
question
multi
function
andor
complex
cov
replic
interestingli
spite
reduc
replic
fidel
revers
mutant
report
thu
far
even
serial
passag
cell
cultur
time
graepel
et
al
howev
long
period
time
passag
mutant
viru
exhibit
eightfold
higher
mutat
frequenc
accumul
varieti
adapt
nonsynonym
mutat
spread
across
genom
partial
compens
replic
defect
decreas
mutagen
sensit
possibl
improv
rdrp
fidel
increas
mutat
robust
graepel
et
al
compensatori
mutat
map
domain
also
subunit
like
helicas
domain
full
revers
mutat
would
requir
total
four
nucleotid
substitut
neither
full
partial
revers
observ
suggest
narrow
evolutionari
pathway
revers
propos
replac
one
activ
site
residu
suffic
minim
exon
activ
observ
exonucleas
e
coli
polymeras
derbyshir
et
al
revers
one
two
motif
site
offer
select
advantag
compar
doubl
mutant
graepel
et
al
view
replic
compet
mhv
sarscov
exonknockout
mutant
summar
strike
equival
mutant
prove
nonviabl
least
three
cov
minskaia
et
al
transmiss
gastroenter
viru
tgev
becar
et
al
recent
also
merscov
accord
extens
mutagenesi
studi
laboratori
use
replicon
system
alphacoronaviru
tgev
genom
replic
sg
mrna
synthesi
found
modestli
reduc
upon
mutagenesi
exon
activ
site
residu
becar
et
al
interestingli
cystohi
chang
second
zncoordin
residu
residu
sever
affect
sg
mrna
synthesi
mildli
affect
genom
replic
upon
introduct
fulllength
tgev
genom
mutat
equival
sarscov
mutant
prevent
recoveri
infecti
progeni
quantit
rtpcr
assay
indic
reduct
accumul
genom
rna
addit
second
mutat
histoci
posit
fourth
zncoordin
residu
strongli
affect
tgev
rna
synthesi
progeni
titer
report
trigger
weaker
tgevinduc
antivir
respons
attribut
reduc
accumul
viral
dsrna
import
pathogenassoci
molecular
pattern
pamp
recogn
innat
immun
sensor
trigger
decreas
mrna
synthesi
ifninduc
immun
factor
cell
cultur
becar
et
al
unfortun
inform
avail
enzymat
activ
replic
fidel
two
tgev
exon
mutant
would
requir
better
understand
interest
phenotyp
mutant
capabl
modul
innat
immun
respons
assumpt
viabl
mutant
possess
increas
exon
activ
could
explain
reduc
level
dsrna
infect
cell
seem
prematur
altern
explan
phenotyp
includ
chang
effici
kinet
rna
synthesi
moreov
report
reduct
viral
doublestrand
rna
accumul
mutant
interpret
caution
conclus
base
sole
situ
immunodetect
dsrna
use
monoclon
antibodi
poorli
defin
specif
cov
dsrna
replic
intermedi
exampl
remain
unknown
chang
protein
composit
subcellular
local
rnasynthes
complex
may
affect
access
dsrna
epitop
immunolabel
experi
result
recent
obtain
exonknockout
mutant
merscov
equal
intrigu
particularli
sinc
merscov
betacoronaviru
like
mhv
sarscov
use
elabor
set
exon
activ
site
mutant
carri
conserv
alanin
substitut
found
exon
inactiv
lethal
merscov
sign
viral
rna
synthesi
discov
cell
transfect
mutant
fulllength
rna
observ
suggest
exon
domain
andor
also
play
direct
basic
role
cov
rna
synthesi
mere
safeguard
longterm
fidel
replic
summar
depend
cov
studi
impact
exon
inactiv
viral
rna
synthesi
rang
complet
block
merscov
variou
degre
impair
residu
rna
product
support
gener
infecti
progeni
case
mhv
sarscov
betacoronavirus
spite
mutat
phenotyp
longterm
consequ
exon
inactiv
seem
limit
propag
cell
cultur
viral
rna
synthesi
might
inde
expect
toler
least
certain
extent
inactiv
proofread
activ
postul
directli
requir
rdrp
activ
mere
boost
overal
qualiti
replic
process
clearli
replic
absenc
function
exon
deleteri
mutat
would
first
accumul
viral
fit
would
begin
decreas
appear
case
third
betacoronaviru
merscov
two
alphacoronavirus
tgev
immedi
full
strong
disrupt
viral
rna
synthesi
observ
exonknockout
mutant
launch
transfect
fulllength
rna
dna
opinion
technic
variat
unlik
explain
viabil
differ
except
tgev
exon
knockout
mutant
commonli
launch
electropor
vitro
produc
fulllength
rna
cytosol
cell
thu
provid
equal
environ
first
critic
round
replic
cell
line
known
compromis
innat
immun
respons
lam
et
al
habjan
et
al
studi
nonviabl
merscov
exon
mutant
attempt
amplifi
progeni
viru
releas
transfect
cell
immunecompet
incompet
cell
eg
vero
cell
respect
equal
neg
outcom
thu
addit
proofread
exon
somehow
appear
play
basic
role
function
cov
rnasynthes
machineri
virtu
exoribonucleas
activ
domain
bifunct
subunit
andor
interact
partner
nsp
viral
rnasynthes
machineri
among
cov
investig
thu
far
mhv
sarscov
experi
stand
two
virus
exhibit
robust
rna
synthesi
overal
replic
cultur
cell
possibl
replic
activ
exondefici
mutant
somehow
need
cross
certain
threshold
result
infecti
progeni
exondefici
mutant
achiev
cov
replic
effici
howev
consid
phenotyp
differ
knockout
mutant
term
viru
viabil
sensit
mutagen
agent
cell
cultur
remain
difficult
reconcil
report
reduct
progeni
titer
exonknockout
mhv
sarscov
complet
loss
infecti
progeni
report
exonknockout
mutant
variou
cov
also
relev
consid
fact
low
level
residu
enzymat
activ
exon
activ
site
mutant
may
go
unnot
biochem
assay
could
still
support
certain
level
replic
launch
rna
exonknockout
cov
mutant
despit
conserv
exon
among
cov
nidovirus
extent
particular
mutat
affect
enzymat
activ
assess
studi
specif
viral
protein
biochem
assay
becar
et
al
case
et
al
case
et
al
interact
host
innat
immun
system
suggest
codetermin
phenotyp
exonknockout
cov
mutant
kindler
thiel
becar
et
al
case
et
al
propos
cov
virtu
exon
activ
may
counteract
innat
respons
degrad
dsrna
replic
intermedi
similar
manner
document
exon
domain
arenaviru
nucleoprotein
hasti
et
al
russier
et
al
cov
employ
rang
innat
immun
evas
mechan
kindler
thiel
difficult
studi
import
singl
mechan
straightforward
manner
innat
immun
antagonist
continu
oper
cell
infect
mutant
lack
one
particular
immun
evas
function
case
et
al
show
mhv
exon
viru
sensit
replic
strongli
attenu
innat
immunecompet
bone
marrowderiv
macrophag
bmm
effect
partial
restor
interferonalphabeta
receptor
knockout
bmm
howev
upon
infect
mhvexon
mutant
neither
upregul
interferon
mrna
express
induct
oasrnasel
pkr
pathway
observ
contrast
would
expect
would
inde
degrad
pamp
like
viral
dsrna
mhv
mutant
yield
progeni
reduc
specif
infect
decreas
rel
fit
properti
attribut
lack
exon
activ
mechan
underli
reduc
fit
alter
ifn
sensit
remain
investig
case
et
al
summar
previou
paragraph
tgev
exon
activ
site
mutant
nonviabl
see
also
mutant
carri
mutat
close
interact
region
report
accumul
less
dsrna
infect
cell
trigger
weaker
antivir
respons
becar
et
al
result
could
taken
suggest
exon
may
modul
innat
immun
respons
tgev
remain
character
biochem
one
specul
level
exon
activ
particular
mutant
sever
cellular
interferonstimul
gene
product
implic
hypermut
viral
genom
remain
establish
directli
properti
exon
mutant
determin
lack
case
et
al
surmis
increas
exoribonucleas
activ
becar
et
al
addit
function
consider
fact
bulk
cov
dsrna
replic
intermedi
found
confin
peculiar
doublemembran
vesicl
part
cov
replic
organel
drive
viral
rna
synthesi
infect
cell
knoop
et
al
neuman
featur
propos
innat
immun
evas
strategi
would
potenti
complic
access
viral
dsrna
substrat
current
fdaapprov
antivir
drug
treatment
cov
mainli
due
limit
interest
side
pharmaceut
industri
despit
loss
human
live
shortliv
sar
outbreak
continu
mer
epidem
moreov
antivir
hit
identifi
far
often
suffer
poor
select
index
drug
develop
effort
restrict
limit
avail
anim
model
potenc
failur
clinic
trial
zumla
et
al
take
account
combin
exon
activ
singl
protein
import
viral
replic
cov
attract
target
antivir
drug
thu
far
two
class
compound
directli
interfer
activ
analyz
detail
nucleosid
analog
methyltransferas
inhibitor
nucleosid
analog
differ
mechan
action
may
interfer
rna
synthesi
directli
instanc
oblig
chain
termin
may
inhibit
viru
replic
indirectli
exampl
induc
lethal
mutagenesi
perturb
intracellular
nucleosid
triphosph
pool
exon
proofread
function
might
counteract
compound
mode
action
order
circumv
nucleosid
would
need
incorpor
effici
excis
exon
resist
exonmedi
remov
crotti
et
al
smith
et
al
warren
et
al
agostini
et
al
recent
spite
potenti
complic
remdesivir
monophosphoramid
prodrug
adenosin
analog
shown
potent
inhibitor
replic
human
zoonot
cov
vivo
vitro
warren
et
al
sheahan
et
al
agostini
et
al
compar
wt
control
replic
mhv
mutant
inhibit
effici
suggest
compound
activ
limit
exon
capabl
excis
remov
incorpor
rna
chain
viral
rdrp
simultan
target
rdrp
exon
function
combin
nucleosid
analog
specif
exoribonucleas
inhibitor
may
also
worth
explor
case
nucleosid
analog
like
ribavirin
approach
may
even
restor
antivir
efficaci
cov
virus
equip
proofread
mechan
ferron
et
al
regard
inhibit
compound
identifi
inhibit
activ
vitro
adenosylhomocystein
aurintricarboxyl
acid
ata
sinefugin
bouvet
et
al
sun
et
al
aouadi
et
al
work
need
optim
hit
order
studi
activ
vivo
investig
specif
viral
enzym
take
account
uniqu
fold
enzym
compar
mtase
might
facilit
drug
develop
specif
compound
target
domain
et
al
ferron
et
al
order
nidoviral
constitut
rna
viru
lineag
display
uniqu
combin
molecular
biolog
featur
includ
genom
size
rang
somewhat
averag
arterivirus
kb
largest
rna
viru
genom
current
known
pscnv
kb
upon
discoveri
promot
relationship
proofread
exonucleas
exon
domain
postul
play
import
role
nidovir
evolut
genom
expans
snijder
et
al
provid
proofread
activ
enhanc
replic
fidel
inde
nidoviru
order
grown
substanti
past
decad
conserv
exon
across
wide
rang
distantli
relat
nidovirus
genom
size
kb
testifi
import
role
enzym
must
play
consequ
role
incorpor
advanc
theoret
model
nidovir
genom
dynam
lauber
et
al
saberi
et
al
ancestr
expans
includ
exon
domain
facilit
subsequ
growth
part
genom
parallel
experiment
evid
accumul
mainli
deriv
studi
wellstudi
betacoronavirus
sarscov
mhv
leav
littl
doubt
involv
exon
fidel
control
genom
replic
minskaia
et
al
eckerl
et
al
eckerl
et
al
bouvet
et
al
graham
et
al
ferron
et
al
increas
genom
size
upper
limit
discoveri
proofread
mechan
constitut
clear
excit
paradigm
shift
rna
virolog
import
question
regard
exon
function
import
remain
resolv
among
wide
phenotyp
variat
among
exonknockout
mutant
differ
cov
speci
studi
thu
far
see
remark
issu
case
appear
particularli
challeng
integr
result
biochemistri
structur
biolog
revers
genet
analysi
covinfect
cell
coher
model
exon
function
might
also
instruct
reassess
increas
mutat
frequenc
evolut
exonknockout
mutant
use
advanc
deepsequenc
method
develop
recent
year
acevedo
et
al
although
key
replic
enzym
cov
cofactor
character
vitro
still
quit
unclear
find
extrapol
viral
enzym
complex
infect
cell
ulfert
et
al
snijder
et
al
impress
longterm
passag
experi
mhv
mutant
graepel
et
al
nice
illustr
complex
plastic
cov
replic
machineri
document
network
compensatori
mutat
varieti
nsp
long
run
help
viru
surviv
circumv
exon
activ
defect
unfortun
studi
technic
challeng
imposs
cov
yield
nonviabl
exonknockout
mutant
context
necessari
expand
biochem
structur
character
cov
replic
enzym
includ
exon
cov
speci
sarscov
elucid
structurefunct
interplay
exon
viral
andor
host
member
cov
replic
machineri
key
understand
role
viral
rna
synthesi
immun
evas
pathogenesi
inform
contribut
design
new
antivir
approach
improv
exist
one
includ
reli
induc
lethal
mutagenesi
ferron
et
al
likewis
allow
better
assess
applic
exon
inactiv
broad
strategi
design
liveattenu
vaccin
cov
nidovirus
graham
et
al
term
vaccin
product
clearli
depend
viabil
exonknockout
mutant
context
would
highli
interest
explor
partial
inactiv
exon
cov
full
inactiv
proven
lethal
metagenom
studi
inform
us
evolutionari
success
remark
broad
host
rang
nidovirus
import
ever
enhanc
prepared
design
strategi
counter
nidovirus
like
emerg
human
anim
host
popul
cp
es
conceiv
wrote
edit
review
ff
ed
bc
revis
extend
part
text
specif
area
biochemistri
structur
biolog
provid
variou
use
suggest
contribut
ff
prepar
